Market News AIOpen the app

NRIX stock news · Nurix Therapeutics

Stories about Nurix Therapeutics (NRIX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NRIX

Follow Nurix Therapeutics (NRIX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NRIX
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 6:47 PM ET · Market

    Nurix Therapeutics said Sanofi will stop the SAR448272 program, impacting future payments and royalties for Nurix.

    Bad for NRIX

    Nurix lost future milestone and royalty eligibility after Sanofi ended SAR448272. Its cash runway and other drug programs remain, but this is bad news for Nurix.

  2. Oct 13, 2026, 6:26 AM ET · Market

    Nurix Therapeutics, Inc. shares its financial results for the quarter ending August 31, 2026.

    Neutral

    Nurix filed a report about quarterly results, but it gives no figures or business updates. It does not show a change in the company's outlook.